⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
IRWD News
Ironwood Pharmaceuticals, Inc. - Class A
Form 8-K
sec.gov
IRWD
Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
businesswire.com
IRWD
Form 8-K/A
sec.gov
IRWD
Form 8-K
sec.gov
IRWD
Form 8-K
sec.gov
IRWD
Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial Guidance
businesswire.com
IRWD
Ironwood Pharmaceuticals to Host First Quarter 2026 Investor Update Call
businesswire.com
IRWD
Convergent Therapeutics Names Andrew Davis Chief Business and Strategy Officer
businesswire.com
DVAX
IRWD
MRK
BHC
Ironwood Pharmaceuticals to Share Real-World HCP Perspectives on Burden of Total Parenteral Nutrition in Short Bowel Syndrome (SBS) at Digestive Disease Week ® 2026
businesswire.com
IRWD
Form 8-K
sec.gov
IRWD